Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

TMK sells Chelyabinsk Metalwork Plant

12/16/25 TRMK

M.Video is expanding its network of service centers M.Master

12/16/25 MVID

NSD will launch a portal to participate in corporate activities

12/16/25 MOEX

Bank Saint Petersburg reported on RAS in November

12/16/25 BSPB

Fix Price bought 73.2 million shares as part of buyback

12/15/25 FIXR

Shareholders of JSCB Primorye approved the exchange of subordination for additional issue shares

12/15/25 PRMB

Shareholders of Avangard Bank approved dividends

12/15/25 AVAN

KLVZ Kristall registers the Trump brand

12/15/25 KLVZ

SFI has withdrawn from its shareholder value creation program

12/15/25 SFIN

Court granted Rusal's claim against Rio Tinto for ₽100 billion

12/15/25 RUAL